MGI Tech Co., Ltd. launches an overseas production line in Latvia to assemble the advanced DNBSEQ-G400* gene sequencing instruments and HotMPS** reagents, marking a significant milestone in MGI's expansion into the European market.
GNOMIX, a global genetics lab renowned for its diverse services, embraces MGI's role in stimulating market competition and shaping the genomics sector.
Celebrating the MGISP-Smart 8's European launch and our Empowerment Program at MEDICA, MGI continues to pioneer genomics research through steadfast innovation.
"We are delighted to be bringing our proven DNBSEQ™ technology to customers and partners in Germany once again," said Dr. Yong Hou.
Latvian Biomedical Research Center Uses MGI's Sequencing Platform for Faster and More Efficient Virus Sequencing in the Fight against the Global Pandemic.
Unveiling MGI's Customer Experience Center in Berlin: Empowering Precision Medicine. Explore MGI's new Customer Experience Center in Berlin, Germany, fostering precision medicine through innovative automation and sequencing. Revolutionize cancer diagnostics, personalized oncology services, and cutting-edge technologies.